M&As this week: Evotec, BioreclamationIVT


German pharmaceutical research company Evotec has acquired US-based drug discovery and development company Aptuit for $300m.

The acquisition will support Evotec’s long-term strategy to become a leader in drug discovery and development.

Biological products provider BioreclamationIVT has acquired biopharmaceutical company Asterand Bioscience.

The acquisition will enable BioreclamationIVT to expand its disease-state biospecimen capabilities.

Both companies involved in the acquisition are based in the US.